nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—Decamethonium—HRH3—attention deficit hyperactivity disorder	0.0323	1	CrCbGaD
Succinylcholine—CHRND—cardiovascular system—attention deficit hyperactivity disorder	0.0125	0.109	CbGeAlD
Succinylcholine—CHRNG—midbrain—attention deficit hyperactivity disorder	0.0123	0.108	CbGeAlD
Succinylcholine—CHRNB1—midbrain—attention deficit hyperactivity disorder	0.00628	0.055	CbGeAlD
Succinylcholine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0061	0.0534	CbGeAlD
Succinylcholine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00555	0.0486	CbGeAlD
Succinylcholine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00516	0.0451	CbGeAlD
Succinylcholine—CHRNA1—brain—attention deficit hyperactivity disorder	0.00511	0.0447	CbGeAlD
Succinylcholine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00497	0.0435	CbGeAlD
Succinylcholine—CHRNB1—cerebellum—attention deficit hyperactivity disorder	0.00486	0.0425	CbGeAlD
Succinylcholine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.0047	0.0411	CbGeAlD
Succinylcholine—BCHE—forebrain—attention deficit hyperactivity disorder	0.00406	0.0355	CbGeAlD
Succinylcholine—CHRNB1—brain—attention deficit hyperactivity disorder	0.00395	0.0345	CbGeAlD
Succinylcholine—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00343	0.03	CbGeAlD
Succinylcholine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00331	0.029	CbGeAlD
Succinylcholine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00319	0.0279	CbGeAlD
Succinylcholine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00301	0.0264	CbGeAlD
Succinylcholine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.0029	0.0254	CbGeAlD
Succinylcholine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.0027	0.0236	CbGeAlD
Succinylcholine—BCHE—midbrain—attention deficit hyperactivity disorder	0.00268	0.0234	CbGeAlD
Succinylcholine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.0026	0.0227	CbGeAlD
Succinylcholine—CHRM2—brain—attention deficit hyperactivity disorder	0.00253	0.0221	CbGeAlD
Succinylcholine—CHRM1—brain—attention deficit hyperactivity disorder	0.0023	0.0202	CbGeAlD
Succinylcholine—BCHE—nervous system—attention deficit hyperactivity disorder	0.0022	0.0193	CbGeAlD
Succinylcholine—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00212	0.0185	CbGeAlD
Succinylcholine—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00207	0.0181	CbGeAlD
Succinylcholine—CHRM3—brain—attention deficit hyperactivity disorder	0.00206	0.018	CbGeAlD
Succinylcholine—BCHE—brain—attention deficit hyperactivity disorder	0.00168	0.0147	CbGeAlD
Succinylcholine—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00087	0.00102	CbGpPWpGaD
Succinylcholine—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000809	0.000948	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000808	0.000947	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00079	0.000926	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000788	0.000923	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00078	0.000914	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000777	0.000911	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000775	0.000908	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000774	0.000907	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000772	0.000904	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000764	0.000896	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000751	0.000881	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000751	0.000881	CbGpPWpGaD
Succinylcholine—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000721	0.000845	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000716	0.00084	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000709	0.000831	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000667	0.000781	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000666	0.000781	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000626	0.000734	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000624	0.000732	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000622	0.000728	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000622	0.000728	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00062	0.000726	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000618	0.000725	CbGpPWpGaD
Succinylcholine—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000613	0.000718	CbGpPWpGaD
Succinylcholine—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000609	0.000713	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000602	0.000705	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000602	0.000705	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0006	0.000703	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000594	0.000696	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00059	0.000691	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000588	0.000689	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000584	0.000685	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000582	0.000682	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000582	0.000682	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000565	0.000663	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000552	0.000647	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000548	0.000642	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000546	0.00064	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000546	0.000639	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000544	0.000638	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00054	0.000633	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000537	0.000629	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000535	0.000627	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00053	0.000621	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000524	0.000614	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000515	0.000604	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000509	0.000597	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000509	0.000596	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000507	0.000595	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000507	0.000594	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000505	0.000592	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000502	0.000589	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000501	0.000587	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000493	0.000578	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000491	0.000576	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000487	0.00057	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000485	0.000568	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000483	0.000566	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000479	0.000561	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000478	0.000561	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000477	0.000559	CbGpPWpGaD
Succinylcholine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000474	0.000556	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000472	0.000554	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00047	0.00055	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000469	0.00055	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000468	0.000548	CbGpPWpGaD
Succinylcholine—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000466	0.000547	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000463	0.000543	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000461	0.00054	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00046	0.00054	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000459	0.000538	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000455	0.000533	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000446	0.000522	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000444	0.000521	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00044	0.000516	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000436	0.000511	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000435	0.000509	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00043	0.000504	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000422	0.000495	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000421	0.000493	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000417	0.000489	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000415	0.000486	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000414	0.000485	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00041	0.00048	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00041	0.00048	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000409	0.000479	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000409	0.000479	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000407	0.000477	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000405	0.000474	CbGpPWpGaD
Succinylcholine—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000404	0.000473	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000403	0.000473	CbGpPWpGaD
Succinylcholine—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000403	0.000472	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000382	0.000448	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000381	0.000446	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000377	0.000442	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000361	0.000423	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00036	0.000422	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000357	0.000419	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000356	0.000417	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000353	0.000413	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00034	0.000399	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000339	0.000397	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000336	0.000393	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000333	0.00039	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000332	0.000389	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000332	0.000389	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000331	0.000388	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000329	0.000385	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000328	0.000384	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000322	0.000377	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000321	0.000376	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000317	0.000372	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000316	0.00037	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000315	0.000369	CbGpPWpGaD
Succinylcholine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000312	0.000366	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000312	0.000366	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000312	0.000366	CbGpPWpGaD
Succinylcholine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000311	0.000365	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000311	0.000365	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000309	0.000362	CbGpPWpGaD
Succinylcholine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000308	0.000361	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000308	0.000361	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000308	0.000361	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000305	0.000357	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000303	0.000355	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000302	0.000353	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000299	0.00035	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000291	0.000341	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00029	0.00034	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000287	0.000336	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000283	0.000331	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000272	0.000319	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000271	0.000318	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000269	0.000315	CbGpPWpGaD
Succinylcholine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000268	0.000313	CbGpPWpGaD
Succinylcholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000267	0.000312	CbGpPWpGaD
Succinylcholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000264	0.000309	CbGpPWpGaD
Succinylcholine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000244	0.000286	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000231	0.000271	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00023	0.00027	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000228	0.000267	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000218	0.000255	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000212	0.000249	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000212	0.000248	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00021	0.000246	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00021	0.000246	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000209	0.000245	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000207	0.000243	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000204	0.000239	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000203	0.000238	CbGpPWpGaD
Succinylcholine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000202	0.000237	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000202	0.000237	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000201	0.000236	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000201	0.000236	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000199	0.000234	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000195	0.000229	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000195	0.000229	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000192	0.000225	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000188	0.00022	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000187	0.000219	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000185	0.000217	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000183	0.000215	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000183	0.000214	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000182	0.000214	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000182	0.000213	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000182	0.000213	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000181	0.000212	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000181	0.000212	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00018	0.000211	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000179	0.00021	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000179	0.000209	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000179	0.000209	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000179	0.000209	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000178	0.000209	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000178	0.000209	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000176	0.000207	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000176	0.000207	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000176	0.000207	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000176	0.000206	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000175	0.000205	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000175	0.000205	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000174	0.000204	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000173	0.000203	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00017	0.0002	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00017	0.000199	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000168	0.000197	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000165	0.000193	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000165	0.000193	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000164	0.000193	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000164	0.000192	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000163	0.000191	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000162	0.00019	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000162	0.00019	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000162	0.00019	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00016	0.000188	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00016	0.000188	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00016	0.000187	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000158	0.000185	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000156	0.000183	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00015	0.000176	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00015	0.000176	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000149	0.000175	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000149	0.000174	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000149	0.000174	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000148	0.000173	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000147	0.000173	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000137	0.000161	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000124	0.000145	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000124	0.000145	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000122	0.000143	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00012	0.000141	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000118	0.000139	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000117	0.000138	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000115	0.000135	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000115	0.000134	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000114	0.000134	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000114	0.000133	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000114	0.000133	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000108	0.000127	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000108	0.000126	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000107	0.000125	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000105	0.000123	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000104	0.000122	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000103	0.000121	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000101	0.000118	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.0001	0.000118	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.94e-05	0.000116	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.75e-05	0.000114	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.72e-05	0.000114	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.63e-05	0.000113	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.58e-05	0.000112	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.55e-05	0.000112	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.47e-05	0.000111	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.46e-05	0.000111	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.44e-05	0.000111	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.34e-05	0.000109	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	9.1e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	9.03e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.82e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.79e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.7e-05	0.000102	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.18e-05	7.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.16e-05	7.21e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.1e-05	7.14e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	5.07e-05	5.94e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	3.9e-05	4.57e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.27e-05	3.83e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.26e-05	3.82e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.23e-05	3.78e-05	CbGpPWpGaD
